In vitro cytotoxic and antioxidant properties of the aqueous, chloroform and methanol extracts of Dicranopteris linearis leaves by Zakaria, ZA et al.
African Journal of Biotechnology Vol. 10 (2), pp. 273-282, 10 December, 2011     
Available online at http://www.academicjournals.org/AJB 
DOI: 10.5897/AJB10.423 





Full Length Research Paper 
 
In vitro cytotoxic and antioxidant properties of the 
aqueous, chloroform and methanol extracts of 
Dicranopteris linearis leaves 
 
Z. A. Zakaria1*, A. M. Mohamed1, N. S. Mohd. Jamil1, M. S. Rofiee2, M. N. Somchit1, A. Zuraini1, 
A. K. Arifah3 and M.R. Sulaiman1 
 
1
Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM 
Serdang, Selangor, Malaysia. 
2
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universiti Teknologi MARA, 40450 Shah Alam, 
Selangor, Malaysia. 
3
Faculty of Veterinar, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. 
 
Accepted 23 September, 2010 
 
The in vitro cytotoxic and antioxidant properties of the aqueous, chloroform and methanol extracts of 
the Dicranopteris linearis leaves were investigated in the present study. The cytotoxic effect was 
determined against the normal (3T3) and cancer cells’ lines (MCF-7, HeLa, HT-29, HL-60, K-562 and 
MDA-MB-231) using the 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay, while 
the antioxidant activity was assessed using the DPPH radical and superoxide scavenging assays. 
Based on the results obtained, the aqueous extract was not effective against any of the types of cancer 
cells studied; the chloroform extract was effective only against MCF-7 and HeLa; and the methanol 
extract was effective against all the cancer cells used. Interestingly, all extracts failed to produce 
cytotoxic effect against the 3T3 cells (normal cell) indicating their safety. All extracts (20, 100 and 500 
µg/ml) were found to exert antioxidant activity when tested using the DPPH radical and superoxide 
scavenging assays; with the methanol, followed by the aqueous and chloroform extracts exhibiting the 
highest antioxidant activity in both assays. The total phenolic content for the aqueous, methanol and 
chloroform extracts were 3112.1 ± 6.7, 3417.3 ± 4.7 and 1012.7 ± 5.3 mg/100 g gallic acid, respectively. In 
conclusion, the leaves of D. linearis possess potential cytotoxic activity against various types of cancer 
cell lines depending on the types of extracts used and antioxidant activity, which need to be further 
explored. 
 






Various species of ferns have been claimed to possess 
enormous economic utility, particularly, their medicinal 
and food importance (Vasuda 1999). Dicranopteris linearis 
(L.) is a type of ferns that belongs to the family 
Gleicheniaceae. Known locally to the Malays as ‘Resam’, 
the plant is traditionally used to reduce body temperature 
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other part of the world, it is used to treat asthma and for 
woman’s sterility (Vasuda 1999), to treat external wound, 
ulcers and broils and to get rid of intestinal worms (Chin, 
1992).  
Previously, various types of flavonoids have been 
successfully isolated and identified from D. linearis (Raja 
et al., 1995) without any attempt to establish its pharma-
cological activities. Recent study has demonstrated that 
the chloroform and aqueous extracts of D. linearis 
possessed antinociceptive, anti-inflammatory, antipyretic 
(Zakaria   et   al.  2006;   2007a)  and  antioxidant  effects 




(Zakaria, 2007b). The objective of the present study is to 
determine the in vitro anticancer and antioxidant activities 
of the aqueous, chloroform and methanol extracts of D. 








The leaves of D. linearis were collected from its natural habitat in 
Shah Alam, Selangor, Malaysia in August-September 2006. The 
plant has been identified earlier by Mr. Shamsul Khamis, a botanist 
at the Institute of Bioscience (IBS), Universiti Putra Malaysia (UPM), 
Serdang, Selangor, Malaysia and a voucher specimen (SK 855/05) 
has been previously deposited at the Herbarium of IBS, UPM. 
 
 
Preparation of aqueous, chloroform and methanol extracts of 
D. linearis  
 
The leaves of D. linearis were air-dried for 1 - 2 weeks at room 
temperature (27 ± 2°C). The dried leaves were then ground into 
small particles, weighed (40 g) and then serially soaked (72 h; room 
temperature) in distilled water (dH2O), chloroform and methanol in 
the ratio of 1:20 (w/v). Each of the mixture solutions were collected 
and filtered using Whatman No. 1 filter paper to obtained the respe-
ctive supernatants. The aqueous extracts were kept in freezer (-
80°C; 48 h) and then subjected to the freeze-drying process. On the 
other hand, the chloroform and methanol extracts were evaporated 
(40°C) under reduced pressure to dryness.  
The freeze-drying process led to a yield of 2.0 g (5.0%) crude 
dried aqueous extracts, while the evaporation of the chloroform and 
methanol extracts of D. linearis resulted in a yield of 2.8 g (7.1%) 
and 2.7 g (6.8%), respectively. All of the crude dried extracts 
obtained were kept at 4°C and, prior to use, the aqueous extracts 
(AEDL) were dissolved in dH2O, while the chloroform (CEDL) and 
methanol (MEDL) extracts were dissolved in dimethyl sulfoxide 
(DMSO) to make up the required concentrations (100 µg/ml). 
 
 
MTT assay (Boehringer Mannheim) 
 
All cell line cultures (MCF-7, HeLa and HT-29) of the American 
Type Culture Collection (ATCC) were purchased from the Institute 
of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, 
Malaysia. They were cultured in Roswell Park Memorial Institute 
1640 supplemented with 10% of fetal bovine serum (FBS), 100 
IU/ml of penicillin and 100 µg/ml of streptomycin using 25-cm
2
 
flasks, in 5% CO2 incubator at 37°C. The viability of cells was deter-
mined with trypan blue reagent. Exponentially growing cells were 
harvested, counted with haemocytometer and diluted with a 
particular medium. Cell culture with the concentration of 1 x 10
5
 
cells/ml was prepared and was plated (100 µl/well) onto 96-well 
plates (NUNCTM, Denmark). The diluted ranges of extracts were 
added to each well and the final concentrations of the test extracts 
were 12.5, 25, 50, and 100 µg/ml. The proliferative activity was 
determined using the MTT assay (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide). The incubation period used was 72 h. 
After solubilization of the purple formazan crystals were completed, 
the spectrophotometrical absorbance of the plants extract was 
measured using an ELISA reader at a wavelength of 550 nm. The 
cytotoxicity was recorded as the drug concentration causing 50% 
growth inhibition of the tumour cells (IC50 value) using the formula 





OD sample (mean) 
% Cell viability =                                         x 100% 
 OD control (mean) 
 
 
After the determination of the percentage of cytotoxicity, graphs 






DPPH radical scavenging activity 
 
Assay for DPPH free radical scavenging potential is based on the 
scavenging activity of stable DPPH free radicals (Carr et al., 1999). 
Reaction mixtures containing test samples dissolved in ethanol and 
reacted with 200 µM DPPH (Sigma) in methanolic solution in a 96-
well microtiter plate were incubated at 37°C for 30 min. After the 
reaction, absorbance was then measured at 520 nm, and percent 
inhibition was calculated.  
 
 
Superoxide anion radical scavenging activity  
 
The superoxide anion radical scavenging activity was performed 
using the method of Okamura et al. (1993) with some modification. 
This assay is based on the removal rate of xanthine/xanthine 
oxidase-generated superoxide by measuring the reduction of nitro 
blue tetrazolium (NBT). The sample solution (0.1 mg/ml) in 5% 
DMSO was added to 1 ml of a mixture of 0.1 mM xanthine and 0.2 
mM NBT (Sigma) in 50 mM potassium phosphate buffer (pH 7.5) 
containing 0.05 mM EDTA. Xanthine oxidase (0.1 ml) (Sigma, USA; 
0.8 unit/mL) diluted in 50 mM phosphate buffer (pH 7.5) was added, 
and the resulting mixture was incubated at 37°C for 20 min. 
Addition of 2 ml of 2.5 N HCl to the mixtures terminated the 
reaction, followed by increase of coloration of NBT, which was 
measured at 540 mM. The percent of removal rate by sample was 
calculated relative to the control.  
 
 
Phytochemical screening of the AEDL, CEDL and MEDL 
 
Phytochemical screening of the AEDL, CEDL and MEDL was 
carried out according to the standard screening tests and conven-
tional protocols (Ikhiri et al. 1992). 
 
 
Determination of the total phenolic contents of the AEDL, 
CEDL and MEDL 
 
The total phenolic content of the AEDL, CEDL and MEDL was 
determined using the Folin–Ciocalteu method as described by 
Ragazzi and Veronese (1973). Briefly, 1.0 ml of each extract was 
added to 10.0 ml distilled water and mixed with 2.0 ml of Folin–Cio-
calteu phenol reagent (Merck-Schuchardt, Hohenbrun, Germany). 
The mixture was allowed to stand at room temperature for 5 min 
and subsequently, 2.0 ml sodium carbonate was added, which 
resulted in the formation of blue complex. The complex was then 
measured at 680 nm with catechin used as a standard for the 
calibration curve. The phenolic compound content was calibrated 
using the linear equation base on the calibration curve. The content 
of phenolic compound was expressed as µg catechin equivalent/g 






Statistical   comparisons   were   carried   out using  student’s  t-test. 










Probability level of P < 0.05 was chosen as the criterion of statistical 





DMSO alone was found to be ineffective in exhibiting 
antiproliferative activity as indicated by its failure to 
produce IC50  against all of the cell lines used in this study 
(data not shown).  
The antiproliferative activity of the AEDL, CEDL and 
MEDL against the normal cell line (3T3) is illustrated in 
Figure 1. Interestingly, all extracts did not produce 
antiproliferative or cytotoxic effect on the cells. Figure 2 
shows the antiproliferative profiles of the AEDL, CEDL 
and MEDL against the MCF-7 cancer cell line. Only the 
CEDL and MEDL demonstrated antiproliferative activity 
against the MCF-7 cells with the IC50 values recorded at 
92 and 99 µg/ml, respectively. The effect of AEDL, CEDL 
and MEDL on the proliferative potential of HeLa cancer 
cell lines is illustrated in Figure 3. Only the CEDL and 
MEDL were found to inhibit the proliferation of HeLa cells 
with IC50 values of approximately 23 and 64 µg/ml, 
respectively. Figure 4 shows the antiproliferative profile of 
the AEDL, CEDL and MEDL against the HL-60 cancer 
cell line. Only the CEDL and MEDL exerted antiprol-
iferative activity against the HL-60 with IC50 values 
recorded at approximately 27 and 9 µg/ml, respectively.  
The antiproliferative profile of the AEDL, CEDL and 
MEDL against the K-562 cancer cell line is shown in 
Figure 5. Only the CEDL and MEDL inhibit the prolife-
ration of K-562 cells with IC50 values recorded at appro-
ximately 88 and 67 µg/ml, respectively. The ability of the 
AEDL, CEDL and MEDL to inhibit the proliferation of HT-
29 cancer cell lines is demonstrated in Figure 6. All 
extracts of D. linearis failed to exert antiproliferative activity 
against the HT-29 cells. 
Interestingly, only MEDL inhibits the proliferation of 
MDA-MB-231 cells with an IC50 value of approximately 40 
µg/ml (Figure 7). Comparison in term of IC50 was also 
performed between the extracts of D. linearis leaves and 
tamoxifen, a standard antitumour drug (Table 1). Overall, 
tamoxifen was a more potent antiproliferative agent 
compared to the three extracts of both plants as indicated 
by its lower IC50 values. 
Table 2 shows the antioxidant activities of AEDL, CEDL 
and MEDL assessed using the DPPH radical scavenging 
and superoxide scavenging assays. The 20, 100 and 500 
µg/ml MEDL produced the highest antioxidant activity 
(between 37.8 – 99.7%) in the DPPH radical scavenging 
test compared to the AEDL (29.3–94.3%) and CEDL 
(13.3 – 66.1%). MEDL also exhibited the highest activity 
in the superoxide scavenging test with an activity ranging 
between 84.2 – 99.7% as compared to the AEDL (62.1 – 
97.4%) and CEDL (33.2 – 71.7%).  
In addition, the total phenolic content evaluation of the 
three extracts indicates that MEDL and AEDL contain the 
highest phenolic content, which is approximately 3417.3 
± 4.7 and 2332.1 ± 5.3 mg/100 g gallic acid, respectively. 
The CEDL total phenolic content was approximately 
1012.7 ± 5.3 mg/100 g gallic acid (Table 3). 
The phytochemical screening of the three extracts 
revealed that AEDL contained saponins, flavonoids, 
tannins; CEDL contained flavonoids, condensed tannins, 
triterpenes and steroids and; MEDL contained saponins, 
flavonoids, condensed tannins and steroids (Table 4). 












Figure 3. In vitro antiproliferative activity of AEDL, CEDL and MEDL against HeLa cancer cell lines. 












Figure 5. In vitro antiproliferative activity of AEDL, CEDL and MEDL against K562 cancer cell lines. 












Figure 7. In vitro antiproliferative activity of AEDL, CEDL and MEDL against MD-MBA-231 cancer cell lines. 








IC50 values µmg/ml) 










AEDL ND ND ND ND ND ND ND 
CEDL ND 92 23 27 88 ND ND 
MEDL ND 99 64 9 67 ND 40 
 
ND: Not detected because the concentration of extracts/drugs required to exhibit IC50 value were above 100 µg/ml (the highest 
concentration used); 
a




Table 2. The antioxidant activity of AEDL, CEDL and MEDL assessed by DPPH radical 
scavenging and superoxide scavenging assays. 
 





AEDL 20 29.3 ± 0.8 62.1 ± 1.3 
100 61.4 ± 2.1 83.0 ± 0.6 
500 94.3 ± 1.2 97.4 ± 0.2 
CEDL 20 13.3 ± 0.2 23.2 ± 0.4 
100 22.6 ± 0.7 41.4 ± 0.1 
500 46.1 ± 1.3 58.7 ± 0.6 
MEDL 20 37.8 ± 1.7 84.2 ± 1.3 
100 85.2 ± 0.6 96.7 ± 0.9 









Total phenolic content 
(mg/100g Gallic acid) 
AEDL 6.25 3112.1 ± 6.7 
CEDL 6.25 1012.7  ± 5.3 
MEDL 6.25 3417.3 ± 4.7 
 
Total phenolic content (TPC) – Expressed as milligram equivalent of 
gallic acid per 100 g of dry weight (mg gallic acid/100 g); TPC value > 




Table 4. The phytochemical constituents of the leaves of M. malabathricum aqueous, 
chloroform and methanol extracts. 
 
Constituent 
Extracts of M. malabathricum leaves 
Aqueous Chloroform Methanol 
Flavonoids + + + 
Triterpenes - - - 
Tannins + + + 
Alkaloids - - - 
Saponins + - + 
Steroids - + + 
 
+: Indicate the presence of respective compound.  




Table 5. The phytochemical constituents of D. 
linearis leaves. 
 








For saponins, +: 1 - 2 cm froth; ++: 2 - 3 cm froth; +++: 
>3 cm froth. 
For flavonoids, tannins, triterpenes and steroids, +: 
weak colour; ++: mild colour; +++: strong colour. 
For akalioids, +: negligible amount of precipitate; ++: 






The present study demonstrated the anticancer profiles 
of three extract of D. linearis whereby AEDL was not 
effective against any of the types of cancer cells studied; 
CEDL was effective only against MCF-7 and HeLa; and 
MEDL was effective against all cancer cells used. Inte-
restingly, all extracts failed to produce cytotoxic effect 
against the 3T3 cells (normal cell) which indicated their 
non-toxic property. The MEDL also exhibited the highest 
antioxidant activity and total phenolic content when 
assessed using the DPPH radical and superoxide 
scavenging assays followed by the CEDL and AEDL.  
The AEDL and CEDL, particularly, have been demo-
nstrated to exhibit antinociceptive, anti-inflammatory, anti-
pyretic (Zakaria et al., 2006, 2007a) and antioxidant 
activities (Zakaria, 2007b). The fact that D. linearis 
showed promising antinociceptive, anti-inflammatory and 
antioxidant activities has triggered the present study. It is 
well known that there are links between the inflammatory 
and nociceptive, oxidative and cancer processes and the 
ability to inhibit any of the processes will definitely lead to 
the inhibition of the others. For example, nitric oxide (NO) 
is produced/released under the action of inflammatory 
stimuli (reactive oxygen species (ROS)) (Olszanecki et 
al., 2002). Inhibition of ROS leads to the reduction of NO 
production, which has been demonstrated to lead to the 
anti-inflammatory, antinociceptive, anticancer and antiox-
idant activities (Middleton et al., 2000; Robak and 
Gryglewski, 1988).  The free radical scavenging property 
may be one of the mechanisms by which this plant is 
effective in the different assays describe earlier and might 
explain the observed anticancer activity.  
Phytochemical screening of D. linearis leaves demon-
strated the presence of flavonoids, saponins, triterpenes, 
tannins and steroids, but no alkaloids (Table 5) (Zakaria 
et al., 2006). Flavonoids, tannins, saponins and triterpenes 
have all been reported to possess antitumor activity (Ye 
et al., 2007; Ferguson et al., 2006; Lemeshko et al., 





has been associated with various mechanisms such as 
the modulation of cell cycle arrest at the G1/S phase, 
induction of cyclin-dependent kinase inhibitors, down-
regulation of anti-apoptotic gene products, inhibition of 
cell-survival kinase and inhibition of inflammatory trans-
cription factors (Agarwal et al., 2006) and induction of 
Ca
2+
-dependent apoptotic mechanism (Sergeev et al., 
2006). Saponins have been reported to induce apoptosis 
by causing permeabilization of the mitochondrial mem-
branes (Lemeshko et al., 2006) or necrotic cell death 
depending on the types of cancer cells (Russo et al., 
2005). Triterpenes were also found to cause cell cycle 
disruption by decreasing the number of cells in G0/G1 
phase, with initial increases in S and G2/M (Roy et al., 
2006) or by inhibiting nuclear factor-kappa B (NF-κB) 
(Lee et al., 2006). The fact that D. linearis also exhibited 
antioxidant activities (Zakaria, 2007b) could also be used 
to support the present finding that antioxidant and anti-
tumor mechanisms are interrelated. Increasing evidences 
have suggested that many age related human diseases, 
including cancer, are the result of cellular damage 
caused by free radicals (Perry et al., 2000; Carr and Frei, 
2000). Antioxidants have been shown to play an 
important role in preventing such diseases. For example, 
several cancer chemopreventive agents exhibit anti-
oxidant activity through their ability to scavenge oxygen 
radicals (Ito et al., 1999; Wei and Frenkel, 1993). The 
present study has also demonstrated the correlation bet-
ween antioxidant activity observed, total phenolic content 
and antiproliferative activity recorded for each of the 
extract, which is in line with report made by Yang et al. 
(2001). Extracts with high total phenolic content (MEDL) 
exhibited high antioxidant capacity suggesting that the 
antioxidant and free radical scavenging properties of 
MEDL contribute directly or indirectly to their observed 
antiproliferative activity (Li et al., 2008).  
The selectivity of those extracts towards cancer cells, 
but not normal cells could be due to several factors such 
as the variety in the coordination of cell cycle’s cellular 
events (Agami and Bernards, 2000; Harper et al., 1993; 
Kato et al., 1994; Hashemolhosseini et al., 1998; 
Paulovich et al., 1997; Ferguson et al., 2004) and the 
ability of the bioactive compounds with potential antipro-
liferative activity to detect and restore those altered 
regulatory factors within the cell cycle coordination, which 
is believed to lead to an effective antitumour activity, and 
the difference in the membrane composition between 
cancer and normal cells (Zwaal and Schroit, 1997; Zwaal 
et al., 2005; Papo et al., 2006).  
In terms of the antiproliferative mechanisms involved, 
several mechanisms could be suggested based on the 
bioactive compounds presence in each of the extracts. Fla-
vonoids, in particular, have been associated with pos-
sible role in the prevention of several chronic diseases 
involving oxidative stress (Lee et al., 2003) as well as 
their anticancer (Middleton et al., 2000), antioxidant 
(Robak and Gryglewski, 1988) and anti-inflammatory 





Flavonoids have also been reported to modulate the 
expression of pro-inflammatory gene, such as nitric oxide 
synthase (NOS) and cyclooxygenase-2 (COX-2) 
(Dawson and Snyder, 1994; Kim et al., 2004). In terms of 
the antiproliferative mechanisms used, Agarwal et al. 
(2006) and Sergeev et al. (2006) have demonstrated that 
flavonoids were capable of inducing the cyclin-dependent 
kinase inhibitors or the Ca
2+
-dependent apoptotic 
mechanism, modulating the cell cycle arrest at the G1/S 
phase, inhibiting the cell-survival kinase and the inflam-
matory transcription factors, or down-regulating the anti-
apoptotic gene products. Saponins and triterpenes have 
also been shown to induce apoptosis response on cancer 
cells, by causing permeabilization of the mitochondrial 
membranes (Lemeshko et al., 2006), to cause necrotic 
cell death (Russo et al., 2005) or cell cycle disruption, by 
decreasing the number of cells in G0/G1 phase, with 
initial increases in S and G2/M (Roy et al., 2006) or by 
inhibiting nuclear factor-kappa B (NF-κB) (Lee et al., 
2006). Other than that, triterpenes were also reported to 
exert antitumour activity via the inhibition of tumour-
induced angiogenesis (Kimura et al., 2002), while Lin et 
al. (2003) reported that triterpenes-induced antitu-mour 
activity involved the suppression of the protein kinase C, 
activating the p38 mitogen-activated protein (MAP) kinase 
and c-Jun N-terminal kinase/stress-activated protein 
kinase (JNK/SAPK), as well as prolonging the G2 cell-
cycle phase in Huh-7 cells. 
Despite the claims on links between the anti-
inflammatory, anti-oxidant and anticancer mechanisms 
discussed earlier (Olszanecki et al., 2002), the failure of 
AEDL to show any cytotoxic effect against all the cancer 
cells tested seems to contradict our earlier findings on its 
anti-inflammatory and antioxidant activity. Thus, it is 
suggested that AEDL uses mechanism of anti-inflam-
matory activity that is different from the mechanism of 
anticancer. For example, the AEDL might only inhibit 
cyclo-oxygenase (COX) action or prostaglandin synthesis 
instead of inhibiting the inflammatory stimuli (NO and 
NOS) (Olszanecki et al., 2002) or inflammatory transc-
ription factors (Agarwal et al., 2006). However, further in-
depth studies are required before final conclusion on the 
mechanisms involved could be drawn to explain the 
observed activity. In conclusion, the extracts of D. linearis 
leaves possess anticancer activity against various types 
of cancer cells and antioxidant activity that are correlated 
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